Michael Huntgeburth
Overview
Explore the profile of Michael Huntgeburth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Busse A, Freilinger S, Eicken A, Ewert P, Freiberger A, Huntgeburth M, et al.
Cardiovasc Diagn Ther
. 2023 Jan;
12(6):840-852.
PMID: 36605078
Background: In the long-term course of treated and untreated congenital heart defects (CHD), pulmonary hypertension (PH) is one of the most relevant complications. Since PH carries a high risk for...
12.
Suleiman M, Freilinger S, Meierhofer C, May M, Bischoff G, Ewert P, et al.
Cardiovasc Diagn Ther
. 2023 Jan;
12(6):787-802.
PMID: 36605074
Background: Aortic aneurysm and aortic dissection can have a major impact on the life expectancy of Marfan syndrome (MFS) or Loeys-Dietz syndrome (LDS) patients. Although obesity can influence the development...
13.
Freiberger A, Busse A, Ewert P, Huntgeburth M, Kaemmerer H, Kohls N, et al.
Cardiovasc Diagn Ther
. 2023 Jan;
12(6):758-766.
PMID: 36605070
Background: Pulmonary vascular disease and pulmonary hypertension (PH) belong to the most relevant complications of congenital heart disease (CHD) in the long-term course. Although PH might lead to a severely...
14.
Strack K, Freilinger S, Busse A, Ewert P, Hauser M, Huntgeburth M, et al.
Cardiovasc Diagn Ther
. 2022 Nov;
12(5):655-670.
PMID: 36329967
Background: Pulmonary arterial hypertension (PAH), a common complication in adults with congenital heart disease (CHD), leads to significant morbidity and mortality. Targeted PAH medication is available, but PAH-CHD patient data...
15.
Sinning C, Huntgeburth M, Fukushima N, Tompkins R, Huh J, Tataneo S, et al.
Cardiovasc Diagn Ther
. 2022 Nov;
12(5):727-743.
PMID: 36329959
Background And Objective: The number of adults with congenital heart disease (ACHD) is increasing worldwide. Almost all congenital cardiac lesions can be successfully treated due to the progress in neonatal...
16.
Huntgeburth M, Hohmann C, Ewert P, Freilinger S, Nagdyman N, Neidenbach R, et al.
Cardiovasc Diagn Ther
. 2022 Jan;
11(6):1334-1343.
PMID: 35070802
Background: Patients with congenital heart defects (CHD) are prone to residua, sequels and complications from the underlying anomaly, where cardiac arrhythmias are one of the major causes for hospitalization, morbidity...
17.
Kaemmerer H, Freilinger S, Neidenbach R, Achenbach S, Andonian C, Ewert P, et al.
Internist (Berl)
. 2022 Jan;
63(1):95-102.
PMID: 34985563
Background: The number of adults with congenital heart disease (ACHD) is steadily increasing. The present cross-sectional study was conceived to investigate ACHD care from the perspective of patients and family...
18.
Kaemmerer H, Andonian C, Ewert P, Freilinger S, Nagdyman N, Neidenbach R, et al.
Dtsch Med Wochenschr
. 2021 Sep;
146(18):1192-1199.
PMID: 34521124
Currently, due to medical advances, more than 500 000 patients with congenital heart defects (CHD) are living in Germany, including more than 330 000 adults. In CHD, the aspect of...
19.
Korber M, Friedrichs K, Aydin F, Pfister R, Mauri V, Baldus S, et al.
Catheter Cardiovasc Interv
. 2020 Oct;
97(6):1236-1243.
PMID: 33002279
Objectives And Background: Percutaneous edge-to-edge mitral valve (MV) repair (PMVR) is broadly applied in high-risk patients with relevant mitral regurgitation (MR). We investigated the incidence of cleft-like indentations (CLI) and...
20.
Pennig L, Wagner A, Weiss K, Lennartz S, Huntgeburth M, Hickethier T, et al.
Int J Cardiovasc Imaging
. 2020 Aug;
37(1):315-329.
PMID: 32852711
To compare a novel Compressed SENSE accelerated ECG- and respiratory-triggered flow-independent 3D isotropic Relaxation-Enhanced Angiography without Contrast and Triggering (modified REACT) with standard non-ECG-triggered 3D contrast-enhanced magnetic resonance angiography (CE-MRA)...